PNL4 COMPARING THE RELATIVE COST-EFFECTIVENESS OF ORAL PROPHYLACTIC MEDICATION VS. BOTULINUM TOXIN TYPE A (BOTOX®) IN THE MANAGEMENT OF MIGRAINE HEADACHE- A MODEL EVALUATING THE CLINICAL AND ECONOMIC IMPACT OF CURRENT TREATMENT OPTIONS
May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64553-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64553-6/fulltext
Section Title :
Section Order :
473
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64553-6&doi=10.1016/S1098-3015(10)64553-6